Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Geke A.H. van den Elsen |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects / Anthony O. Ahmed en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.9 (Septiembre)
[artículo]
Título : Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects : A randomized controlled trial Tipo de documento: texto impreso Autores: Anthony O. Ahmed, Autor ; Geke A.H. van den Elsen, Autor ; Angela P.H. Colbers, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1475-1482 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Anciano, Seguridad, Farmacocinética, Delta-9-tetrahidrocannabinol, Cannabinoides Resumen: There is a great concern about the safety of THC-based drugs in older people (≥65 years), as most of THC-trials did not include such group. In this phase 1, randomized, double-blind, double-dummy, placebo-controlled, cross-over trial, we evaluated the safety and pharmacokinetics of three oral doses of Namisol®, a novel THC in tablet form, in older subjects. Link: ./index.php?lvl=notice_display&id=26921
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.9 (Septiembre) . - pp. 1475-1482[artículo] Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects : A randomized controlled trial [texto impreso] / Anthony O. Ahmed, Autor ; Geke A.H. van den Elsen, Autor ; Angela P.H. Colbers, Autor . - 2021 . - pp. 1475-1482.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.9 (Septiembre) . - pp. 1475-1482
Palabras clave: Anciano, Seguridad, Farmacocinética, Delta-9-tetrahidrocannabinol, Cannabinoides Resumen: There is a great concern about the safety of THC-based drugs in older people (≥65 years), as most of THC-trials did not include such group. In this phase 1, randomized, double-blind, double-dummy, placebo-controlled, cross-over trial, we evaluated the safety and pharmacokinetics of three oral doses of Namisol®, a novel THC in tablet form, in older subjects. Link: ./index.php?lvl=notice_display&id=26921